[
Abstract]
[
Full Text PDF] (in Japanese / 2996KB)
[Members Only And Two Factor Auth.]
J.Jpn. Surg. Soc.. 89(10): 1594-1602, 1988
Original article
PHARMACODYNAMIC STUDY OF THE IN VITRO CLONOGENIC ASSAY
-WITH REFERENCE TO THE DOSE LEVELS-
To determine the optimal condition of the clonogenic assay, the antitumor activities of 5-fluorouracil (5-FU)
in vitro and
in vivo were investigated from a pharmacodynamic viewpoint using 8 human carcinoma xenografts.
The clonogenic assay was performed by the continuous exposure method, and the antitumor effects were evaluated by the colony survival rates (T/Cs). The
in vivo experimental chemotherapy was also performed by the nude mouse system, and the results were evaluated by the T/C ratios of the tumor weights. For pharmacokinetic analyses, the area under the concentration curves (AUCs) of 5-FU
in vitro and
in vivo were computed.
The T/Cs of 5-FU were highly correlated to the AUCs both
in vitro and
in vivo. By using these AUC-T/C correlations, the concentration of 5-FU in the clonogenic assay to predict the T/C of the maximum tolerated dose in mouse was calculated to be 3μg/ml mathematically. This concentration was then verified by the clonogenic assay, where T/Cs
in vitro could successfully correspond to the T/Cs
in vivo. (The predictable rate was 87.5%)
From these results, this pharmacodynamic comparison between
in vitro and
in vivo chemosensitivities was thought to be a promising method for determining the conditions of the clonogenic assay.
To read the PDF file you will need Adobe Reader installed on your computer.